Skip to content

Clinical trials

Observational Kidney Diseases trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Kidney Diseases Phase: Observational Country / region: China Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20021
20072
20091
20121
20132
20161
20191
20201
20213
20222
20231
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Recruiting4
Unknown status4
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Guangdong Provincial People's Hospital2
Zhejiang University2
AstraZeneca1
B.Braun Avitum AG1
Cancer Foundation, China1
Chinese University of Hong Kong1
First Affiliated Hospital of Wenzhou Medical University1
George (Beijing) Clinical Research Co. Ltd.1
Huashan Hospital1
Jinling Hospital, China1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Kidney Diseases19
Diabetic Nephropathies3
Renal Insufficiency, Chronic3
Carcinoma, Renal Cell2
Cardio-Renal Syndrome2
Coronary Artery Disease2
Glomerulonephritis2
Glomerulonephritis, IGA2
Kidney Neoplasms2
Metabolic Syndrome2

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.